🇺🇸 FDA
Patent

US 7994205

Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

granted A61KA61K31/40A61K31/415

Quick answer

US patent 7994205 (Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/40, A61K31/415, A61K31/417, A61K31/4178